Close

Articles

Risking Addiction for Relief: Is There a Better Alternative to Opioids?

Every day, the United States loses 116 lives to the opioid epidemic.(1) Pharmacists are asking what can be done to combat the opioid epidemic and treat pain effectively. In the ever-changing healthcare environment, minimizing pain is a top priority, but...

Commercial Pharma: It’s reboot time

CRM, CLM, KAM, Big Data, customer focus, patient centricity… for the last 20 years,buzzwords and concepts have been raining down on the Pharmaceutical Industry, generating a flurry of projects, proof of concepts, pilots and even some successful implementations. Consultants were...

Quality Systems for Regenerative Medicine Delivery; Basic Quality Requirements for Distribution

The emergence of regenerative medicine as a viable therapy class has created an urgency  to review and improve upon the current quality systems distribution standards that are employed in support of these therapies. Industry efforts are already underway through both...

Streamlining the supply chain with aggregation

The introduction of serialization or track and trace legislation has been driven by global demand for increased patient safety, by shaping a more secure supply chain that puts patients front of mind for drug manufacturers and their partners. But while...

Collaborative Robots in the Pharma Business

Automation has expanded its base in various sectors of the manufacturing industry and the application of robotics is gaining wide acceptance in well – defined processes like the FMCG industry, automotive, healthcare industry, pharma industry, etc. Even with the...

API in India and the Global Market

Environmental concerns in China leading to closure of factories that make the basic raw materials and key starting materials required for the API industry to be dearer? There has been a consistent increase in KSM (Key starting material) prices for...

Packaging Trends and the Future of the Generics Market in India

Around the world, the pharmaceutical market is rapidly evolving, driven by greater access to medicines, an increased focus on patient needs and the emergence of innovative therapies for chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis. Industry analyst...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read